Mylan Announces Final Approval For Meloxicam Tablets

Sat, 22 Jul 2006 11:00 AM EST

... Mylan Laboratories Inc.(NYSE: MYL) today announced that the U.S. Food and Drug Administration hasgranted final approval for Mylan Pharmaceuticals Inc.'s Abbreviated NewDrug Application for Meloxicam Tablets, 7.5 mg and 15 mg. Meloxicam Tablets are indicated for the relief of the signs andsymptoms of osteoarthritis. [click link for full article] ...